ConductScience.org, home

Paper42623398

A single dose of azithromycin versus placebo for malaria in infants: A cluster-randomized trial.

Ihamuotila R and 13 others. PLOS Glob Public Health, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. A single dose of azithromycin versus placebo for malaria in infants: A cluster-randomized trial. Papers, record 42623398. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42623398

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A single dose of azithromycin versus placebo for malaria in infants: A cluster-randomized trial.
PubMed
Journal
PLOS Glob Public Health
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-23
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ihamuotila RRikhardhttps://orcid.org/0000-0002-2624-5298
2Juma JJane
3Haidara FFadima
4Samaké OOumar
5Luoma JJuhohttps://orcid.org/0000-0003-0008-8295
6Adubra LLaura
7Cheung YBYin Bunhttps://orcid.org/0000-0003-0517-7625
8Alber DDagmar
9Traoré AAwa
10Ducker CCamilla
11Ashorn UUlla
12Ashorn PPer
13Sow SSamba
14Fan YMYue-Meihttps://orcid.org/0000-0002-3241-6225

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
INV-003354Bill & Melinda Gates FoundationUnited StatesPubMed
INV-005877Bill & Melinda Gates FoundationUnited StatesPubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04424511Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in MaliDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129694816Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.N Engl J Med2018https://conductscience.org/library/papers/29694816PubMed
234315475Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness.Malar J2021https://conductscience.org/library/papers/34315475PubMed
335337289Malaria positivity following a single oral dose of azithromycin among children in Burkina Faso: a randomized controlled trial.BMC Infect Dis2022https://conductscience.org/library/papers/35337289PubMed
441506755Integration of azithromycin mass administration to 1-11-month-old children into an existing health platform to reduce child mortality: a cluster-randomised trial in Burkina Faso.BMJ Glob Health2026https://conductscience.org/library/papers/41506755PubMed
531237871Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial.PLoS Med2019https://conductscience.org/library/papers/31237871PubMed
619724043Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.JAMA2009https://conductscience.org/library/papers/19724043PubMed
720219090Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replication.Malar J2010https://conductscience.org/library/papers/20219090PubMed
821328286Azithromycin for treating uncomplicated malaria.Cochrane Database Syst Rev2011https://conductscience.org/library/papers/21328286PubMed
931443654The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study.Malar J2019https://conductscience.org/library/papers/31443654PubMed
1041092331Mass Administration of Azithromycin to Infants in Mali to Reduce Mortality.N Engl J Med2025https://conductscience.org/library/papers/41092331PubMed
1130699301Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention.N Engl J Med2019https://conductscience.org/library/papers/30699301PubMed
1241130195Mass Azithromycin Distributions and Childhood Clinic Visits in Niger: A Community-Randomized Trial.Am J Trop Med Hyg2025https://conductscience.org/library/papers/41130195PubMed
1316354821A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.Am J Trop Med Hyg2005https://conductscience.org/library/papers/16354821PubMed
1438397717Evaluation of the Performance of Rapid Diagnostic Tests for Malaria Diagnosis and Mapping of Different Plasmodium Species in Mali.Int J Environ Res Public Health2024https://conductscience.org/library/papers/38397717PubMed
1533942345Measuring association among censored antibody titer data.Stat Med2021https://conductscience.org/library/papers/33942345PubMed
1640824641Biannual Mass Azithromycin Distributions for Preschool Children and Malaria Parasitemia: A Secondary Analysis of the MORDOR Cluster Randomized Trial.JAMA Netw Open2025https://conductscience.org/library/papers/40824641PubMed
1731485189A validation study of microscopy versus quantitative PCR for measuring Plasmodium falciparum parasitemia.Trop Med Health2019https://conductscience.org/library/papers/31485189PubMed
1830911048Molecular quantification of Plasmodium parasite density from the blood retained in used RDTs.Sci Rep2019https://conductscience.org/library/papers/30911048PubMed
1940638118Spillover of Azithromycin Mass Drug Administration and Child Survival: A Secondary Analysis of a Cluster-Randomized Clinical Trial.JAMA Netw Open2025https://conductscience.org/library/papers/40638118PubMed
2037968741
Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali.
Trials2023https://conductscience.org/library/papers/37968741PubMed

See all 45 referencesDownload CSV of references

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
AZITHROMYCINCHEMBL529Derived from the trial1https://conductscience.org/library/drugs/CHEMBL529

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Cited by
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42623398

GET https://conductscience.org/api/papers/v1/42623398/references?page=2